<p><strong>Articore Group Limited</strong> (ASX:ATG) 的股票在經歷了一段動盪期後，最近一個月表現非常出色，漲幅達到 28%。回顧過去一年，儘管最近 30 天表現強勁，但過去 12 個月的 21% 漲幅也算不錯。</p>
<p>儘管價格大幅反彈，Articore Group 的市銷率（&#34;P/S&#34;）為 0.2 倍，與澳大利亞的多元零售行業相比，仍然顯得具有吸引力，因為該行業約有一半的公司市銷率超過 0.8 倍，甚至市銷率超過 3 倍的情況也相當普遍。不過，我們需要深入分析，以確定市銷率降低是否有合理的依據。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>查看我們對 Articore Group 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36276704-ps-multiple-vs-industry-1-dark-2/1769112109599?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36276704-ps-multiple-vs-industry-1-dark-2/1769112109599"/></p>
<p>ASX:ATG 市銷率與行業比較 2026 年 1 月 22 日</p>
<h3>Articore Group 的市銷率對股東意味着什麼？</h3>
<p>最近，Articore Group 的表現不佳，其收入下降與其他公司相比顯得尤為糟糕，後者的收入平均有所增長。似乎許多人預計糟糕的收入表現將持續，這抑制了市銷率。因此，儘管可以説該股票便宜，但投資者希望在看到其價值之前，能夠看到改善的跡象。</p>
<p>如果您想了解分析師對未來的預測，可以查看我們對 Articore Group 的 <strong>免費</strong> 報告。</p>
<h2>收入增長指標告訴我們關於低市銷率的什麼？</h2>
<p>有一個內在假設，即公司應該表現不如行業，才能使像 Articore Group 這樣的市銷率被視為合理。</p>
<p>首先回顧一下，去年公司的收入增長並不令人興奮，出現了令人失望的 11% 的下降。過去三年也不太好，公司總共減少了 24% 的收入。因此，不幸的是，我們必須承認公司在這段時間內未能很好地實現收入增長。</p>
<p>展望未來，預計未來三年將帶來減少的回報，收入預計每年下降 3.2%，這是由關注該公司的雙重分析師估算的。在行業其他公司預計每年增長 6.0% 的情況下，這並不理想。</p>
<p>鑑於此，Articore Group 的市銷率低於大多數其他公司是可以理解的。不過，考慮到收入在下降，市銷率是否已經觸底並沒有保證。如果公司不改善其收入增長，市銷率可能會進一步下降。</p>
<h2>關鍵要點</h2>
<p>Articore Group 的股價最近飆升，但其市銷率仍然保持在適中水平。一般來説，我們傾向於將市銷率的使用限制在評估市場對公司整體健康狀況的看法上。</p>
<p>顯然，Articore Group 由於預期收入下滑而維持低市銷率是顯而易見的。由於行業內其他公司預計收入增長，Articore Group 的糟糕前景也為其低市銷率提供了合理性。在這種情況下，很難看到股價在近期內強勁上漲。</p>
<p>始終需要考慮投資風險的潛在威脅。我們已識別出 <strong>Articore Group 的 1 個警示信號</strong>，理解這一點應成為您投資過程的一部分。</p>
<p>如果您對 Articore Group 的業務實力 <strong>不確定</strong>，何不探索我們互動式的股票列表，尋找一些您可能錯過的基本面良好的其他公司呢？</p>

ATRC

<p>Articore Group Limited (ASX:ATG) 的股票最近上漲了 28%，但其市銷率（P/S）仍然較低，為 0.2 倍，表明可能被低估。儘管過去一年增長了 21%，但公司在收入方面面臨困境，去年收入下降了 11%，三年來下降了 24%。分析師預測，未來每年收入將進一步減少 3.2%，而行業預計增長為 6%。這種疲軟的前景解釋了低市銷率，使得近期股價大幅上漲的可能性不大</p>

<p><strong>Articore Group Limited</strong> (ASX:ATG) shares have had a really impressive month, gaining 28% after a shaky period beforehand. Looking further back, the 21% rise over the last twelve months isn't too bad notwithstanding the strength over the last 30 days.</p>
<div class="lb-trans"><p><strong>Articore Group Limited</strong> (ASX:ATG) 的股票在經歷了一段動盪期後，最近一個月表現非常出色，漲幅達到 28%。回顧過去一年，儘管最近 30 天表現強勁，但過去 12 個月的 21% 漲幅也算不錯。</p>
</div><p>In spite of the firm bounce in price, Articore Group's price-to-sales (or &#34;P/S&#34;) ratio of 0.2x might still make it look like a buy right now compared to the Multiline Retail industry in Australia, where around half of the companies have P/S ratios above 0.8x and even P/S above 3x are quite common. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the reduced P/S.</p>
<div class="lb-trans"><p>儘管價格大幅反彈，Articore Group 的市銷率（&#34;P/S&#34;）為 0.2 倍，與澳大利亞的多元零售行業相比，仍然顯得具有吸引力，因為該行業約有一半的公司市銷率超過 0.8 倍，甚至市銷率超過 3 倍的情況也相當普遍。不過，我們需要深入分析，以確定市銷率降低是否有合理的依據。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行探索。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>Check out our latest analysis for Articore Group</p>
<div class="lb-trans"><p>查看我們對 Articore Group 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/36276704-ps-multiple-vs-industry-1-dark-2/1769112109599" alt="" original-src="https://images.simplywall.st/asset/chart/36276704-ps-multiple-vs-industry-1-dark-2/1769112109599"/></p>
<p>ASX:ATG Price to Sales Ratio vs Industry January 22nd 2026</p>
<div class="lb-trans"><p>ASX:ATG 市銷率與行業比較 2026 年 1 月 22 日</p>
</div><h3>What Does Articore Group's P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>Articore Group 的市銷率對股東意味着什麼？</h3>
</div><p>Articore Group hasn't been tracking well recently as its declining revenue compares poorly to other companies, which have seen some growth in their revenues on average. It seems that many are expecting the poor revenue performance to persist, which has repressed the P/S ratio. So while you could say the stock is cheap, investors will be looking for improvement before they see it as good value.</p>
<div class="lb-trans"><p>最近，Articore Group 的表現不佳，其收入下降與其他公司相比顯得尤為糟糕，後者的收入平均有所增長。似乎許多人預計糟糕的收入表現將持續，這抑制了市銷率。因此，儘管可以説該股票便宜，但投資者希望在看到其價值之前，能夠看到改善的跡象。</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on Articore Group.</p>
<div class="lb-trans"><p>如果您想了解分析師對未來的預測，可以查看我們對 Articore Group 的 <strong>免費</strong> 報告。</p>
</div><h2>What Are Revenue Growth Metrics Telling Us About The Low P/S?</h2>
<div class="lb-trans"><h2>收入增長指標告訴我們關於低市銷率的什麼？</h2>
</div><p>There's an inherent assumption that a company should underperform the industry for P/S ratios like Articore Group's to be considered reasonable.</p>
<div class="lb-trans"><p>有一個內在假設，即公司應該表現不如行業，才能使像 Articore Group 這樣的市銷率被視為合理。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 11%. The last three years don't look nice either as the company has shrunk revenue by 24% in aggregate. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>首先回顧一下，去年公司的收入增長並不令人興奮，出現了令人失望的 11% 的下降。過去三年也不太好，公司總共減少了 24% 的收入。因此，不幸的是，我們必須承認公司在這段時間內未能很好地實現收入增長。</p>
</div><p>Turning to the outlook, the next three years should bring diminished returns, with revenue decreasing 3.2% per annum as estimated by the dual analysts watching the company. That's not great when the rest of the industry is expected to grow by 6.0% each year.</p>
<div class="lb-trans"><p>展望未來，預計未來三年將帶來減少的回報，收入預計每年下降 3.2%，這是由關注該公司的雙重分析師估算的。在行業其他公司預計每年增長 6.0% 的情況下，這並不理想。</p>
</div><p>In light of this, it's understandable that Articore Group's P/S would sit below the majority of other companies. Nonetheless, there's no guarantee the P/S has reached a floor yet with revenue going in reverse. There's potential for the P/S to fall to even lower levels if the company doesn't improve its top-line growth.</p>
<div class="lb-trans"><p>鑑於此，Articore Group 的市銷率低於大多數其他公司是可以理解的。不過，考慮到收入在下降，市銷率是否已經觸底並沒有保證。如果公司不改善其收入增長，市銷率可能會進一步下降。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>關鍵要點</h2>
</div><p>Articore Group's stock price has surged recently, but its but its P/S still remains modest. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>Articore Group 的股價最近飆升，但其市銷率仍然保持在適中水平。一般來説，我們傾向於將市銷率的使用限制在評估市場對公司整體健康狀況的看法上。</p>
</div><p>It's clear to see that Articore Group maintains its low P/S on the weakness of its forecast for sliding revenue, as expected. As other companies in the industry are forecasting revenue growth, Articore Group's poor outlook justifies its low P/S ratio. It's hard to see the share price rising strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>顯然，Articore Group 由於預期收入下滑而維持低市銷率是顯而易見的。由於行業內其他公司預計收入增長，Articore Group 的糟糕前景也為其低市銷率提供了合理性。在這種情況下，很難看到股價在近期內強勁上漲。</p>
</div><p>It's always necessary to consider the ever-present spectre of investment risk. We've identified <strong>1 warning sign with Articore Group</strong>, and understanding should be part of your investment process.</p>
<div class="lb-trans"><p>始終需要考慮投資風險的潛在威脅。我們已識別出 <strong>Articore Group 的 1 個警示信號</strong>，理解這一點應成為您投資過程的一部分。</p>
</div><p>If you're <strong>unsure about the strength of Articore Group's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您對 Articore Group 的業務實力 <strong>不確定</strong>，何不探索我們互動式的股票列表，尋找一些您可能錯過的基本面良好的其他公司呢？</p>
</div>

Articore Group Limited (ASX:ATG) 即便股價上漲了 28%，仍因增長不足而受到限制